Abbvie Inc. vs Edwards Lifesciences Corp
ABBV vs EW — side-by-side comparison from reported financials. ABBV leads 5, EW leads 5 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Edwards Lifesciences Corp
EW · Healthcare
$85.21+1.15%Strong
| Metric | ABBV | EW |
|---|---|---|
| Price | $276.43 | $85.21 |
| Market cap | $488B | $49.1B |
| Revenue (TTM) | $64.4B | $6.51B |
| Revenue growth | +1.8% | +4.1% |
| Net margin | 9.8% | 15.4% |
| Free cash flow | $18.2B | $1.43B |
| Net cash (debt) | ($56.2B) | $3.63B |
| 1-year price return | +19.8% | +13.3% |
| P/E | 77.4 | 48.9 |
| P/E vs own history (cheap-side %) | 23% | 11% |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | 10% |
| Altman Z-score | 2.33 | 11.86 |
| CV checks passed | 9 of 11 | 9 of 11 |
| Employees | 57,000 | 16,000 |
Full résumé-style profiles: ABBV CV · EW CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.